Sage Therapeutics, Inc. (SAGE) Reports Q4 Loss, Misses Revenue Estimates

Sage Therapeutics, Inc. (SAGE) delivered earnings and revenue surprises of 1.85% and 8.27%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for…